Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ACTH 1-17 and sexual behavior.

A Isidori, L Di Luigi, D Conte

    La Ricerca in Clinica E in Laboratorio
    |April 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Adrenocorticotropic hormone (ACTH) 1-17 significantly improved sexual performance in men with psychogenic impotence. This effect was observed without altering key hormonal levels, suggesting a direct central nervous system action.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy.

    Journal of endocrinological investigation·2022
    Same author

    Antimicrobial resistance in Aeromonas species isolated from aquatic environments in Brazil.

    Journal of applied microbiology·2020
    Same author

    Exercise-induced GH secretion is related to puberty.

    Journal of endocrinological investigation·2020
    Same author

    Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase's type 5 inhibitors on DHT response to exercise-related stress.

    Journal of endocrinological investigation·2020
    Same author

    Vitamin D, sport and health: a still unresolved clinical issue.

    Journal of endocrinological investigation·2020
    Same author

    The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.

    Journal of endocrinological investigation·2019
    Same journal

    Increase of plasma tissue-plasminogen activator antigen levels after induced abortion.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Role of prostaglandin E2 on defective interferon-gamma production during type B acute viral hepatitis.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The use of recombinant factor VIII in the management of hemophilia.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The functioning liver mass.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. V. Activation-extinction line of cyclic hepatocyte activities.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. IV. More on the liver micro-unit: physics and geometry of its action.

    La Ricerca in clinica e in laboratorio·1991
    See all related articles

    Area of Science:

    • Neuroendocrinology
    • Sexual Medicine
    • Psychiatry

    Background:

    • Psychogenic impotence affects men without identifiable organic causes.
    • Sexual behavior is influenced by complex hormonal and neurological factors.
    • Adrenocorticotropic hormone (ACTH) 1-17 is a peptide hormone with potential systemic effects.

    Purpose of the Study:

    • To investigate the effect of ACTH 1-17 on sexual behavior in men with psychogenic impotence.
    • To determine if hormonal changes mediate the effects of ACTH 1-17 on sexual function.

    Main Methods:

    • A group of male patients diagnosed with psychogenic impotence was administered ACTH 1-17.
    • Sexual performance was assessed before and after treatment.
    • Hormonal parameters including gonadotropins, sexual steroids, and adrenal steroids were monitored.

    Related Experiment Videos

    Main Results:

    • ACTH 1-17 administration resulted in a significant increase in sexual performance.
    • No significant changes were observed in any of the measured hormonal parameters.
    • The treatment did not affect gonadotropin, sexual steroid, or adrenal steroid levels.

    Conclusions:

    • ACTH 1-17 demonstrates a beneficial effect on sexual behavior in psychogenic impotence.
    • The therapeutic action of ACTH 1-17 appears to be mediated by the central nervous system (CNS).
    • The observed improvements are not hormone-mediated, indicating a direct CNS effect.